当前位置:首页 - 行情中心 - 重药控股(000950) - 财务分析 - 现金流量表

重药控股

(000950)

  

流通市值:115.44亿  总市值:115.44亿
流通股本:17.28亿   总股本:17.28亿

现金流量表

报告期2026-03-312025-12-312025-09-302025-06-30
公司类型通用通用通用通用
一、经营活动产生的现金流量:
  销售商品、提供劳务收到的现金20,196,351,385.4292,156,419,477.0465,602,358,700.942,660,741,820.78
  收到的税费返还-0--
  收到其他与经营活动有关的现金413,641,514.482,439,535,741.111,387,935,328.321,636,159,929.66
  经营活动现金流入小计20,609,992,899.994,595,955,218.1566,990,294,029.2244,296,901,750.44
  购买商品、接受劳务支付的现金21,958,766,531.9186,075,400,363.6664,046,357,537.842,452,981,236.96
  支付给职工以及为职工支付的现金551,084,585.331,884,333,443.881,437,480,216.31951,192,706.47
  支付的各项税费480,353,448.31,549,825,517.881,040,794,159.32723,806,052.69
  支付其他与经营活动有关的现金935,963,247.784,331,725,803.352,795,927,277.192,442,412,117.2
  经营活动现金流出小计23,926,167,813.3293,841,285,128.7769,320,559,190.6246,570,392,113.32
  经营活动产生的现金流量净额-3,316,174,913.42754,670,089.38-2,330,265,161.4-2,273,490,362.88
二、投资活动产生的现金流量:
  收回投资收到的现金-339,416,960.5374,645,860.53-
  取得投资收益收到的现金-119,038,363.74119,038,363.74119,038,363.74
  处置固定资产、无形资产和其他长期资产收回的现金净额82,3081,011,324701,013235,480.47
  处置子公司及其他营业单位收到的现金净额-399,607.57399,607.57399,607.57
  收到的其他与投资活动有关的现金13,652,243.8858,449,051.4140,450,520.9219,755,717.84
  投资活动现金流入小计13,734,551.88518,315,307.25235,235,365.76139,429,169.62
  购建固定资产、无形资产和其他长期资产支付的现金99,833,118.4299,539,838.25206,624,194.56130,917,613.1
  投资支付的现金-0-0
  质押贷款净增加额-0-0
  取得子公司及其他营业单位支付的现金-25,203,406.4225,203,347.0223,140,657.13
  支付其他与投资活动有关的现金-29,823,589.5965,171,073.1830,370,442.85
  投资活动现金流出小计99,833,118.4354,566,834.26296,998,614.76184,428,713.08
  投资活动产生的现金流量净额-86,098,566.52163,748,472.99-61,763,249-44,999,543.46
三、筹资活动产生的现金流量:
  吸收投资收到的现金-238,713,461.4132,323,83019,028,830
  其中:子公司吸收少数股东投资收到的现金-238,713,461.4132,323,83019,028,830
  取得借款收到的现金6,027,596,568.8824,752,970,472.5517,572,518,985.4811,484,513,993.63
  收到其他与筹资活动有关的现金200,276,681.06392,200,549.65362,070,243.53281,454,140.61
  筹资活动现金流入小计6,227,873,249.9425,383,884,483.6117,966,913,059.0111,784,996,964.24
  偿还债务支付的现金3,663,771,379.2124,114,209,320.9817,205,788,644.8911,234,408,564.5
  分配股利、利润或偿付利息支付的现金218,372,485.891,170,710,564.26903,337,673.06551,495,180.18
  其中:子公司支付给少数股东的股利、利润7,188,840.32297,144,355.83180,691,927.1446,375,235.72
  支付其他与筹资活动有关的现金169,185,859.851,053,399,419.07526,162,335.86326,247,058.27
  筹资活动现金流出小计4,051,329,724.9526,338,319,304.3118,635,288,653.8112,112,150,802.95
  筹资活动产生的现金流量净额2,176,543,524.99-954,434,820.7-668,375,594.8-327,153,838.71
五、现金及现金等价物净增加额-1,225,729,954.95-36,016,258.33-3,060,404,005.2-2,645,643,745.05
  加:期初现金及现金等价物余额4,750,966,315.914,786,982,574.244,786,982,574.244,786,982,574.24
  期末现金及现金等价物余额3,525,236,360.964,750,966,315.911,726,578,569.042,141,338,829.19
补充资料:
  净利润-521,328,438.97-388,988,353.43
  资产减值准备-909,318,679.07-2,991,945.06
  固定资产和投资性房地产折旧-239,347,525.35-122,708,600.9
  其中:固定资产折旧、油气资产折耗、生产性生物资产折旧-239,347,525.35-122,708,600.9
  无形资产摊销-36,333,178.67-25,054,788.76
  长期待摊费用摊销-58,564,157.16-31,385,670.99
  处置固定资产、无形资产和其他长期资产的损失--4,629,873.82--1,202,756.45
  固定资产报废损失--189,424.35--
  公允价值变动损失-3,068,104.51-861,030.74
  财务费用-758,261,522.73-379,653,270.8
  投资损失--415,481,340.47--58,201,620.47
  递延所得税--275,511,823.92--26,032,430.08
  其中:递延所得税资产减少--308,971,250.41--24,964,750.86
    递延所得税负债增加-33,459,426.49--1,067,679.22
  存货的减少--149,151,116.18--315,335,259.71
  经营性应收项目的减少--2,800,383,331.27--3,335,799,063.08
  经营性应付项目的增加-1,673,291,496.93-711,018,620.83
  其他----299,209,682.74
  现金的期末余额-4,750,966,315.91-2,141,338,829.19
  减:现金的期初余额-4,786,982,574.24-4,786,982,574.24
  加:现金等价物的期末余额---0
  减:现金等价物的期初余额---0
  现金及现金等价物的净增加额--36,016,258.33--2,645,643,745.05
公告日期2026-04-242026-04-242025-10-282025-08-21
审计意见(境内)标准无保留意见
TOP↑